Skip to content

The Effect of Leukocyte and Platelet-rich Fibrin With Antimicrobial Photodynamic Therapy in Aggressive Periodontitis

The Effect of Leukocyte and Platelet-rich Fibrin With Antimicrobial Photodynamic Therapy in Treatment of Aggressive Periodontitis Patients: A Randomized Controlled Clinical Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05043935
Enrollment
20
Registered
2021-09-14
Start date
2021-11-22
Completion date
2024-10-31
Last updated
2024-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aggressive Periodontitis, L-PRF, Photodynamic Therapy

Brief summary

Antimicrobial photodynamic therapy (aPDT) is associated with photosensitizing agents which promote the generation of free radicals and singlet oxygen, which are cytotoxic to certain bacteria. Leukocyte and platelet-rich fibrin (L-PRF) has been used extensively in the treatment of intrabony defects and achieved excellent results. It acts as an immune regulation node with inflammation control abilities, including a slow continuous release of growth factors which stimulates periodontal regeneration. The aim of this study is to evaluate the adjunctive effects of aPDT with and without L-PRF in aggressive periodontitis patients.

Interventions

PROCEDUREL-PRF with antimicrobial photodynamic therapy

Application of L-PRF with antimicrobial photodynamic therapy in the defect

PROCEDUREantimicrobial photodynamic therapy without L-PRF

application of antimicrobial photodynamic therapy without L-PRF in the defect

Sponsors

Kafrelsheikh University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* systemically healthy * non- smoker, * not received any periodontal treatment within the last 6 months, * no antibiotics, anti- inflammatory drugs or any other medication taken within the last 6 months

Exclusion criteria

* any systemic disease that might influence the prognosis of periodontal disease and outcome of the treatment, * any medical condition that required antibiotic prophylaxis before the treatment, * smoking, * pregnancy and lactation, * ingestion of antibiotics, anti-inflammatory drugs or any other medication during the study period, * any physical limitations or restrictions that might preclude normal oral hygiene procedures.

Design outcomes

Primary

MeasureTime frameDescription
Clinical evaluation and measurements of the defect in millimeters9 monthsChanges in clinical measurements in millimeters after application of antimicrobial photodynamic therapy with and without L-PRF
Radiographic evaluation and measurements of the defect in millimeters9 monthsChanges in bone formation in millimeters after application of antimicrobial photodynamic therapy with and without L-PRF

Countries

Egypt

Contacts

Primary ContactDalia R Issa, PhD
dalia_rasheed@hotmail.com01007753636

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026